Immunosuppressants: A Drug Therapy For Psoriasis Management In Geriatrics

Immunosuppressive medications are frequently utilized to manage autoimmune skin disorders, stemming from an overactive immune system. Nonetheless, their prolonged usage in elders can lead to serious side effects. Consequently, continuous monitoring is essential throughout treatment to promptly identify adverse effects. One of the most significant risks is an increased susceptibility to infections. Since immunosuppressants lower the body's natural defenses, patients become more vulnerable to bacterial, viral, and fungal infections. This risk is compounded in older adults, whose immune systems are already less robust. Another major concern is the heightened risk of cancers. The suppression of the immune system can reduce the body's ability to detect and destroy cancerous cells, leading to a higher incidence of malignancies. Additionally, long-term immunosuppressive therapy can cause metabolic issues, including diabetes, hypertension, and osteoporosis, further complicating the health status of elderly patients. Regular check-ups and tests are necessary to identify and manage any adverse effects promptly. This proactive approach helps to mitigate risks, ensuring that the benefits of immunosuppressive treatment outweigh the drawbacks, particularly in vulnerable elderly populations.

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2024-10-24
DOI
https://doi.org/10.5281/zenodo.13987697
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunosuppressants: A Drug Therapy For Psoriasis Management In Geriatrics

Zenodo (CERN European Organization for Nuclear Research)
Psoriasis: Treatment and Pathogenesis
article

Immunosuppressants: A Drug Therapy For Psoriasis Management In Geriatrics

article en

Abstract

Immunosuppressive medications are frequently utilized to manage autoimmune skin disorders, stemming from an overactive immune system. Nonetheless, their prolonged usage in elders can lead to serious side effects. Consequently, continuous monitoring is essential throughout treatment to promptly identify adverse effects. One of the most significant risks is an increased susceptibility to infections. Since immunosuppressants lower the body's natural defenses, patients become more vulnerable to bacterial, viral, and fungal infections. This risk is compounded in older adults, whose immune systems are already less robust. Another major concern is the heightened risk of cancers. The suppression of the immune system can reduce the body's ability to detect and destroy cancerous cells, leading to a higher incidence of malignancies. Additionally, long-term immunosuppressive therapy can cause metabolic issues, including diabetes, hypertension, and osteoporosis, further complicating the health status of elderly patients. Regular check-ups and tests are necessary to identify and manage any adverse effects promptly. This proactive approach helps to mitigate risks, ensuring that the benefits of immunosuppressive treatment outweigh the drawbacks, particularly in vulnerable elderly populations.

Zenodo (CERN European Organization for Nuclear Research)
Openalex Percentile: Top 52%
Psoriasis: Treatment and Pathogenesis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.